PMA device
Navistar Rmt Thermocool Catheter
Biosense Webster, Inc. · Cardiac Ablation Percutaneous Catheter (LPB, Class III) · First FDA decision Jan 4, 2008, newest Jul 1, 2014Atrial fibrillation
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
6
PMA pathway
Device trials
2
Naming "Navistar Rmt Thermocool"
MAUDE reports
32
Brand "Navistar Rmt Thermocool", since 2015
PubMed studies
0
Mentioning "Navistar Rmt Thermocool"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Navistar Rmt Thermocool Catheter
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 6 of 6 decisions filed under this name.
- NAVISTAR RMT THERMOCOOL CATHETERPMA supplement
P040036-S032 · Decided Jul 1, 2014 · 728 days after receipt · Normal 180 Day Track No User Fee
Device type: Cardiac ablation percutaneous catheter (LPB) · Cardiology
P040036-S008 · Decided Feb 20, 2009 · 224 days after receipt · Normal 180 Day Track
Device type: Cardiac ablation percutaneous catheter (LPB) · Cardiology
- NAVISTAR RMT THERMOCOOL LINE EXTENSIONPMA supplement
P040036-S003 · Decided Jan 4, 2008 · 280 days after receipt · Normal 180 Day Track
Device type: Cardiac ablation percutaneous catheter (LPB) · Cardiology
3 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Cardiac Catheterization Performed In Other Than A Hospital SettingNational analysisReview closedCAG-00166NUpdated Sep 16, 2026
- Cardiac Catheterization Performed in Other than a Hospital Setting - RETIREDNational determinationOn the books20.25Updated Dec 3, 2024
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33959CGS Administrators, LLCUpdated Oct 30, 2026
- Cardiac Catheterization and Coronary AngiographyLocal determinationIn effectL33557Wellpoint FederalUpdated Jul 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "Navistar Rmt Thermocool", any status and sponsor, newest update first.
- Comparison of VT Ablation Outcomes Using Remote MAGNETIC Navigation Versus Manual Approach in a Low LVEF PopulationPivotal-lookingTerminated
StereotaxisPublic (STXS)
NCT02637947 · 182 participants · Start Jan 2016 · Primary completion Feb 15, 2022
Device: catheter ablation using magnetic navigation; catheter ablation using manual navigation · For: Tachycardia, Ventricular
Sites: Orlando, Florida; Augusta, Georgia; Chicago, Illinois · 16 sites in all
StereotaxisPublic (STXS)
NCT00851279 · 53 participants · Start Jun 2009 · Primary completion Oct 2012
Device: Magnetic irrigated ablation catheter · For: Ventricular Tachycardia
Sites: Indianapolis, Indiana; Philadelphia, Pennsylvania; Prague, Czechia · 4 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Navistar Rmt Thermocool", and for the whole product code for context.
This brand
32 reports: 6 malfunction, 24 injury, 2 death
Whole product code LPB
14,593 reports: 5,424 malfunction, 8,535 injury, 628 death
Newest reports for this brand
- NAVISTAR RMT THERMOCOOLInjury
2029046-2025-04076 · Received Dec 9, 2025 · Event dated Nov 13, 2025
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Device problem as coded: Patient Device Interaction Problem
Patient problem as coded: Cardiac Tamponade
- NAVISTAR RMT THERMOCOOLInjury
2029046-2025-03874 · Received Nov 20, 2025 · Event dated Oct 23, 2025
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Device problem as coded: Patient Device Interaction Problem
Patient problem as coded: Cardiac Tamponade
- NAVISTAR RMT THERMOCOOLInjury
2029046-2025-03387 · Received Oct 7, 2025 · Event dated Sep 11, 2025
Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Device problem as coded: Patient Device Interaction Problem
Patient problem as coded: Cardiac Tamponade
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Johnson & Johnson Surgical Vision, Inc.
Z-0169-2023 · Started Sep 7, 2022 · Posted by FDA Nov 2, 2022
Reason given: Manufacturing error resulted in potential contamination of Bi-Directional navigation catheter irrigation path with cellulose fibers that can cause 1) Failure of initial flushing inspection, 2) Insufficient irrigation causing catheter tip temperature increase, limiting the ability to deliver ablation, or 3) particles...
Cause as FDA categorized it: Process control · Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Flutter (OAD)
Z-0139-2015 · Started Oct 19, 2014 · Posted by FDA Oct 27, 2014
Reason given: The recall was initiated because Biosense Webster is providing additional labeling for the safe and effective use of the ThermoCool SmartTouch Catheter.
Cause as FDA categorized it: Use error · Device type: Cardiac Ablation Percutaneous Catheter (LPB)
Z-0979-2012 · Started Nov 22, 2010 · Posted by FDA Feb 7, 2012
Reason given: Biosense Webster, Inc. has recently become aware of the omission of the following two Warning and Precaution statements on the Instructions For Use (IFU) for the above catheter: 1. If phrenic nerve location is a concern, precautionary measures are recommended to evaluate the proximity of the nerve to the ablation...
Cause as FDA categorized it: Labeling design · Device type: Catheter, Percutaneous, Cardiac Ablation, For Treatment Of Atrial Fibrillation (OAE)
5 more recall records with a free account
Published research
The most relevant PubMed records for "Navistar Rmt Thermocool"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code LPB.
- Therapy Ablation Catheter (4mm and 8mm)Irvine Biomedical, Inc. · PMA 2022
- Navistar ThermocoolBiosense Webster, Inc. · PMA 2014
- EZ Steer ThermoCool CatheterBiosense Webster, Inc. · PMA 2021
- Chilli II Cooled Ablation Catheter and CableBoston Scientific Corp · PMA 2020
- Livewire Tc Ablation Catheter, Safire Ablation CatheterSt Jude Medical · PMA 2016
- Chilli Cooled Ablation SystemBoston Scientific Corp · PMA 2011
- Blazer II Cardiac Ablation System and CableBoston Scientific Corp · PMA 2025
- Freezor Cardiac Cryoablation CatheterMedtronic Cryocath, LP · PMA 2022
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.